COOPER COMPANIES, INC. (COO)
About COOPER COMPANIES, INC.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $4.1B
- Net income
- $374.9M
- Total assets
- $12.4B
- Market cap
- $13.7B
- Gross margin
- 65.5%
- Operating margin
- 16.7%
- Net margin
- 9.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.1B
- Cost of revenue
- $1.4B
- Gross profit
- $2.7B
- Operating expenses
- $2.0B
- Operating income
- $682.9M
- Income tax
- $191.6M
- Net income
- $374.9M
- EPS (basic)
- $1.88
- EPS (diluted)
- $1.87
Balance sheet
- Total assets
- $12.4B
- Current assets
- $2.1B
- Total liabilities
- $4.2B
- Current liabilities
- $1.1B
- Shareholders’ equity
- $8.2B
Cash flow
- Operating cash flow
- $796.1M
- Investing cash flow
- -$372.9M
- Financing cash flow
- -$425.9M
- Net cash flow
- $2.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $13.7B
- P/E ratio
- 37.6
- EPS (diluted)
- $1.87
- Dividend yield
- 0.09%
- Shares outstanding
- 186.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 21, 1983
Cooper Companies, Inc. (COO) Stock Price
- Profitable — net income of $374.9M in FY2025.
- Revenue grew 40% from FY2021 to FY2025.
- Gross margin of 65.5%, net margin 9.2%.
- Trading 17% below its 52-week high.
- Pays a dividend yielding about 0.09% annually.
- Valued at a price-to-earnings (P/E) ratio of 37.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review COOPER COMPANIES, INC..
Write a review
News about COOPER COMPANIES, INC.
News & sentiment via Polygon.io
Cooper Companies, Inc.: frequently asked questions
Is Cooper Companies, Inc. an American company?
Yes — Cooper Companies, Inc. is an American company headquartered in San Ramon, California. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Cooper Companies, Inc. headquartered?
Cooper Companies, Inc. is headquartered in San Ramon, California, United States.
Is Cooper Companies, Inc. publicly traded?
Yes — Cooper Companies, Inc. is a publicly traded company. Its stock trades under the ticker symbol COO on the NASDAQ.
What does Cooper Companies, Inc. do?
Cooper Companies, Inc. is an American Medical Devices company in the Health & Beauty sector.
